Skip to main content
Fig. 3 | Cell Communication and Signaling

Fig. 3

From: Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma

Fig. 3

Survival analysis and prognostic validity of the risk signature in CGGA dataset. a The risk score distribution and survival overview of glioma patients. b-d Kaplan-Meier analyses of risk score for patient survival. e ROC analysis of age, grade and risk score for predicting 3-year survival of patients. f ROC analysis of age, grade and risk score for predicting 5-year survival of patients. g-h Univariate and multivariate Cox regression analyses of risk score and several other clinical pathologic features

Back to article page